[go: up one dir, main page]

WO2011114350A3 - Huile de boswellia, ses fractions et compositions pour augmenter la fonction cérébrale - Google Patents

Huile de boswellia, ses fractions et compositions pour augmenter la fonction cérébrale Download PDF

Info

Publication number
WO2011114350A3
WO2011114350A3 PCT/IN2011/000170 IN2011000170W WO2011114350A3 WO 2011114350 A3 WO2011114350 A3 WO 2011114350A3 IN 2011000170 W IN2011000170 W IN 2011000170W WO 2011114350 A3 WO2011114350 A3 WO 2011114350A3
Authority
WO
WIPO (PCT)
Prior art keywords
boswellia
memory
compositions
fraction
fractions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2011/000170
Other languages
English (en)
Other versions
WO2011114350A2 (fr
Inventor
Ganga Raju Gokaraju
Rama Raju Gokaraju
Venkata Kanaka Ranga Raju Gokaraju
Trimurtulu Golakoti
Kiran Bhupathiraju
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laila Nutraceuticals
Original Assignee
Laila Nutraceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laila Nutraceuticals filed Critical Laila Nutraceuticals
Priority to MYPI2012700603A priority Critical patent/MY173288A/en
Priority to CN2011800138938A priority patent/CN102811728A/zh
Priority to AU2011228689A priority patent/AU2011228689A1/en
Priority to PH1/2012/501787A priority patent/PH12012501787A1/en
Priority to CA2793045A priority patent/CA2793045A1/fr
Priority to BR112012022983A priority patent/BR112012022983A2/pt
Priority to SG2012067229A priority patent/SG184006A1/en
Publication of WO2011114350A2 publication Critical patent/WO2011114350A2/fr
Publication of WO2011114350A3 publication Critical patent/WO2011114350A3/fr
Priority to US13/616,283 priority patent/US8828377B2/en
Anticipated expiration legal-status Critical
Priority to US13/689,478 priority patent/US10286023B2/en
Priority to US14/451,565 priority patent/US9795646B2/en
Priority to AU2016201084A priority patent/AU2016201084B2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La présente invention concerne un extrait/fraction non acide sélectionné à partir d'une fraction d'extrait de gomme-résine faiblement polaire de Boswellia (BLPRE), d'une fraction d'huile volatile de Boswellia (BVOIL) et d'une fraction d'huile de Boswellia (BOIL) dérivés de la gomme-résine de l'espèce Boswellia et leurs compositions pour améliorer la mémoire/l'état mental, augmenter les fonctions cérébrales/mentales telles que la cognition, la mémoire, l'apprentissage, la communication et la santé cérébrale, pour traiter le déficit mnésique, et pour prévenir, lutter contre ou traiter les troubles/maladies associés à la mémoire et à la cognition.
PCT/IN2011/000170 2008-09-15 2011-03-14 Huile de boswellia, ses fractions et compositions pour augmenter la fonction cérébrale Ceased WO2011114350A2 (fr)

Priority Applications (11)

Application Number Priority Date Filing Date Title
MYPI2012700603A MY173288A (en) 2010-03-15 2011-03-14 Boswellia oil, its fractions and compositions for enhancing brain function
CN2011800138938A CN102811728A (zh) 2010-03-15 2011-03-14 用于提高大脑功能的乳香油、其分馏物及组合物
AU2011228689A AU2011228689A1 (en) 2010-03-15 2011-03-14 Boswellia oil, its fractions and compositions for enhancing brain function
PH1/2012/501787A PH12012501787A1 (en) 2010-03-15 2011-03-14 Boswellia oil, its fractions and compositions for enhancing brain function
CA2793045A CA2793045A1 (fr) 2010-03-15 2011-03-14 Huile de boswellia, ses fractions et compositions pour augmenter la fonction cerebrale
BR112012022983A BR112012022983A2 (pt) 2010-03-15 2011-03-14 óleo de bosvélia, sua frações e composições para melhoria do funcionamento cerebral
SG2012067229A SG184006A1 (en) 2010-03-15 2011-03-14 Boswellia oil, its fractions and compositions for enhancing brain function
US13/616,283 US8828377B2 (en) 2010-03-15 2012-09-14 Boswellia oil, its fractions and compositions for enhancing brain function
US13/689,478 US10286023B2 (en) 2008-09-15 2012-11-29 Compositions comprising non-acidic Boswellia oil fraction as a bio-enhancer for enhancing bioavailability of biological agents
US14/451,565 US9795646B2 (en) 2010-03-15 2014-08-05 Boswellia oil, its fractions and compositions for enhancing brain function
AU2016201084A AU2016201084B2 (en) 2010-03-15 2016-02-22 Boswellia Oil, Its Fractions And Compositions For Enhancing Brain Function

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN687/CHE/2010 2010-03-15
IN687CH2010 IN2010CH00687A (fr) 2010-03-15 2011-03-14

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2011/000364 Continuation-In-Part WO2011151840A2 (fr) 2008-09-15 2011-05-26 Compositions comprenant une fraction non acide d'huile de boswellia comme bio-activateur pour améliorer la biodisponibilité d'agents biologiques

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US13/584,099 Continuation-In-Part US8551496B2 (en) 2008-09-15 2012-08-13 Boswellia low polar gum resin extract and its synergistic compositions
US13/616,283 Continuation-In-Part US8828377B2 (en) 2010-03-15 2012-09-14 Boswellia oil, its fractions and compositions for enhancing brain function

Publications (2)

Publication Number Publication Date
WO2011114350A2 WO2011114350A2 (fr) 2011-09-22
WO2011114350A3 true WO2011114350A3 (fr) 2011-11-10

Family

ID=54291846

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2011/000170 Ceased WO2011114350A2 (fr) 2008-09-15 2011-03-14 Huile de boswellia, ses fractions et compositions pour augmenter la fonction cérébrale

Country Status (8)

Country Link
CN (1) CN102811728A (fr)
AU (2) AU2011228689A1 (fr)
BR (1) BR112012022983A2 (fr)
CA (1) CA2793045A1 (fr)
IN (1) IN2010CH00687A (fr)
MY (1) MY173288A (fr)
SG (1) SG184006A1 (fr)
WO (1) WO2011114350A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011151840A2 (fr) * 2010-05-30 2011-12-08 Laila Nutraceuticals Compositions comprenant une fraction non acide d'huile de boswellia comme bio-activateur pour améliorer la biodisponibilité d'agents biologiques
GB201111319D0 (en) * 2011-07-04 2011-08-17 Univ Leuven Kath Anticonvulsant activity of tumeric oil and bisabolene sesquiterpenoids of curcuma longa
EP3209300B1 (fr) 2014-10-21 2022-03-16 Alpinia Laudanum Institute Of Phytopharmaceutical Sciences AG Extrait d'une plante du genre boswellia et produits connexes et utilisations
EP3283094B1 (fr) 2015-04-13 2020-10-21 Ethnodyne Utilisation d'un extrait de withania pour le traitement d' -synucléinopathies
CN113648292A (zh) * 2017-05-16 2021-11-16 四川省中医药科学院 四氢姜黄素在制备提高记忆力的药物或保健品中的用途
CN107349190B (zh) * 2017-07-19 2021-04-23 广东工业大学 芳姜黄酮的应用
IT201900013707A1 (it) * 2019-08-01 2021-02-01 Cristalfarma S R L Integratore alimentare, per uso come coadiuvante, per la prevenzione della demenza vascolare
US20230113013A1 (en) * 2020-03-03 2023-04-13 Laila Nutrceuticals Synergistic compositions for improving brain health
WO2021205083A2 (fr) 2020-04-11 2021-10-14 Finindsutria Srl Composition pour la prévention ou le traitement du covid-19
CN116370523B (zh) * 2023-04-04 2024-08-13 昆明理工大学 植物精油在制备抗癫痫药物或健康产品中的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070248693A1 (en) * 2003-08-02 2007-10-25 Elizabeth Mazzio Nutraceutical composition and method of use for treatment / prevention of cancer
US20080275117A1 (en) * 2006-09-21 2008-11-06 Dan Li Compositions and Methods Comprising Boswellia Species

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4444288A1 (de) * 1994-12-13 1996-06-20 Rainer Dr Med Etzel Verwendung von Weihrauch zur Behandlung der Alzheimer-Krankheit
US7873730B2 (en) * 2003-11-10 2011-01-18 International Business Machines Corporation Method and system for collaborative computing environment access restriction and orphan data management
CN1583063B (zh) * 2004-06-10 2012-03-28 山东齐都药业有限公司 乳香有效成分提取方法及提取物制剂和用途

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070248693A1 (en) * 2003-08-02 2007-10-25 Elizabeth Mazzio Nutraceutical composition and method of use for treatment / prevention of cancer
US20080275117A1 (en) * 2006-09-21 2008-11-06 Dan Li Compositions and Methods Comprising Boswellia Species

Also Published As

Publication number Publication date
AU2016201084B2 (en) 2017-10-19
IN2010CH00687A (fr) 2011-08-31
SG184006A1 (en) 2012-10-30
CA2793045A1 (fr) 2011-09-22
BR112012022983A2 (pt) 2015-09-15
MY173288A (en) 2020-01-13
CN102811728A (zh) 2012-12-05
AU2016201084A1 (en) 2016-03-17
AU2011228689A1 (en) 2012-09-27
WO2011114350A2 (fr) 2011-09-22

Similar Documents

Publication Publication Date Title
WO2011114350A3 (fr) Huile de boswellia, ses fractions et compositions pour augmenter la fonction cérébrale
PH12012501787A1 (en) Boswellia oil, its fractions and compositions for enhancing brain function
WO2010021693A3 (fr) Modulateurs de mif
WO2010048446A3 (fr) Modulation de la dégénérescence d'axons
WO2011055215A3 (fr) Nouveaux modulateurs de kinase
HK1259102A1 (zh) 用於治疗微生物病症的amp
WO2008052166A3 (fr) Systèmes et procédés pour modifier les fonctions et traiter les conditions et les maladies du cerveau et du corps
CY1121136T1 (el) Φυτικα εκχυλισματα που περιεχουν κανναβινοειδη ως νευροπροστατευτικους παραγοντες
WO2011090738A3 (fr) Inhibiteurs de kinase raf de type ii
WO2011140202A3 (fr) Modulateurs de mif
HK1223093A1 (zh) 杀真菌组合物
MX2012004638A (es) Modulacion de degeneracion de axones.
WO2015002754A3 (fr) Nouveaux inhibiteurs de bromodomaines bicycliques
WO2011133875A3 (fr) Composés inhibiteurs de métalloenzyme
WO2012020307A3 (fr) Utilisations thérapeutiques de microvésicules et de microarn associés
WO2011048617A3 (fr) Extraits, fractions et compositions comprenant des acetogenines et leurs applications
WO2014149138A3 (fr) Composition et procédé de lutte contre les poux
WO2014121302A3 (fr) Compositions et procédés
WO2011082245A3 (fr) Composés inhibiteurs de métallo-enzyme
WO2007092622A3 (fr) Compositions et méthodes pour le traitement d'os
WO2007089548A3 (fr) Composés et procédés de modulation du trafic de protéines
WO2012064943A3 (fr) Composés inhibiteurs de métalloenzymes
WO2006091459A3 (fr) Compositions et methodes permettant de traiter la permeabilite vasculaire
EP3581177A3 (fr) Compositions comprenant des extraits acides de résine de lentisque
WO2014126965A3 (fr) Compositions et méthodes pour traiter une calcification et une ossification pathologiques

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201180013893.8

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11755793

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2011228689

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 12012501787

Country of ref document: PH

ENP Entry into the national phase

Ref document number: 2793045

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2011228689

Country of ref document: AU

Date of ref document: 20110314

Kind code of ref document: A

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112012022983

Country of ref document: BR

122 Ep: pct application non-entry in european phase

Ref document number: 11755793

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 112012022983

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20120912